NO20061791L - Polymorf form av 3-fenylsulfonyl-8-piperazin-1-yl-kinolin - Google Patents
Polymorf form av 3-fenylsulfonyl-8-piperazin-1-yl-kinolinInfo
- Publication number
- NO20061791L NO20061791L NO20061791A NO20061791A NO20061791L NO 20061791 L NO20061791 L NO 20061791L NO 20061791 A NO20061791 A NO 20061791A NO 20061791 A NO20061791 A NO 20061791A NO 20061791 L NO20061791 L NO 20061791L
- Authority
- NO
- Norway
- Prior art keywords
- phenylsulfonyl
- piperazin
- quinoline
- polymorphic form
- cns
- Prior art date
Links
- JJZFWROHYSMCMU-UHFFFAOYSA-N 3-(benzenesulfonyl)-8-piperazin-1-ylquinoline Chemical compound C=1N=C2C(N3CCNCC3)=CC=CC2=CC=1S(=O)(=O)C1=CC=CC=C1 JJZFWROHYSMCMU-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0322629.7A GB0322629D0 (en) | 2003-09-26 | 2003-09-26 | Novel compound |
| PCT/EP2004/010843 WO2005040124A1 (en) | 2003-09-26 | 2004-09-23 | A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061791L true NO20061791L (no) | 2006-04-24 |
Family
ID=29286934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061791A NO20061791L (no) | 2003-09-26 | 2006-04-24 | Polymorf form av 3-fenylsulfonyl-8-piperazin-1-yl-kinolin |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20070032504A1 (da) |
| EP (1) | EP1667975B1 (da) |
| JP (1) | JP2007506702A (da) |
| CN (1) | CN1856471A (da) |
| AU (1) | AU2004283805A1 (da) |
| BR (1) | BRPI0414678A (da) |
| CA (1) | CA2540022A1 (da) |
| CO (1) | CO5680402A2 (da) |
| DE (1) | DE602004010410T2 (da) |
| DK (1) | DK1667975T3 (da) |
| ES (1) | ES2297465T3 (da) |
| GB (1) | GB0322629D0 (da) |
| HR (1) | HRP20080055T3 (da) |
| IL (1) | IL174213A0 (da) |
| IS (1) | IS8399A (da) |
| MA (1) | MA28093A1 (da) |
| MX (1) | MXPA06003375A (da) |
| NO (1) | NO20061791L (da) |
| PL (1) | PL1667975T3 (da) |
| PT (1) | PT1667975E (da) |
| RU (1) | RU2355681C2 (da) |
| WO (1) | WO2005040124A1 (da) |
| ZA (1) | ZA200601453B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE398108T1 (de) * | 2002-03-27 | 2008-07-15 | Glaxo Group Ltd | Chinolinderivate und deren verwendung als 5-ht6 liganden |
| HRP20060100T3 (en) | 2003-07-22 | 2007-03-31 | Arena Pharmaceuticals Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| BRPI0410979A (pt) | 2003-09-18 | 2006-07-04 | Axys Pharm Inc | composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia |
| KR100978954B1 (ko) | 2005-06-02 | 2010-08-30 | 에프. 호프만-라 로슈 아게 | Ｇａｂａ-ｂ 증강인자로서 3-메테인설폰일퀴놀린 |
| GB0519758D0 (en) * | 2005-09-28 | 2005-11-09 | Glaxo Group Ltd | Novel process |
| ES2389958T3 (es) * | 2007-03-21 | 2012-11-05 | Glaxo Group Limited | Uso de derivados de quinolina en el tratamiento del dolor |
| US9084742B2 (en) | 2007-12-12 | 2015-07-21 | Axovant Sciences Ltd. | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
| WO2017011767A2 (en) | 2015-07-15 | 2017-01-19 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
| CN108290842B (zh) * | 2016-05-27 | 2021-04-06 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的喹啉化合物及其药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| ATE398108T1 (de) * | 2002-03-27 | 2008-07-15 | Glaxo Group Ltd | Chinolinderivate und deren verwendung als 5-ht6 liganden |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-09-26 PT PT04765655T patent/PT1667975E/pt unknown
- 2003-09-26 GB GBGB0322629.7A patent/GB0322629D0/en not_active Ceased
-
2004
- 2004-09-23 CN CNA2004800275278A patent/CN1856471A/zh active Pending
- 2004-09-23 RU RU2006114024/04A patent/RU2355681C2/ru active
- 2004-09-23 JP JP2006527373A patent/JP2007506702A/ja not_active Withdrawn
- 2004-09-23 MX MXPA06003375A patent/MXPA06003375A/es active IP Right Grant
- 2004-09-23 DE DE602004010410T patent/DE602004010410T2/de not_active Expired - Fee Related
- 2004-09-23 BR BRPI0414678-6A patent/BRPI0414678A/pt not_active IP Right Cessation
- 2004-09-23 US US10/572,670 patent/US20070032504A1/en not_active Abandoned
- 2004-09-23 EP EP04765655A patent/EP1667975B1/en not_active Expired - Lifetime
- 2004-09-23 HR HR20080055T patent/HRP20080055T3/xx unknown
- 2004-09-23 PL PL04765655T patent/PL1667975T3/pl unknown
- 2004-09-23 ES ES04765655T patent/ES2297465T3/es not_active Expired - Lifetime
- 2004-09-23 CA CA002540022A patent/CA2540022A1/en not_active Abandoned
- 2004-09-23 WO PCT/EP2004/010843 patent/WO2005040124A1/en not_active Ceased
- 2004-09-23 DK DK04765655T patent/DK1667975T3/da active
- 2004-09-23 AU AU2004283805A patent/AU2004283805A1/en not_active Abandoned
-
2006
- 2006-02-20 ZA ZA200601453A patent/ZA200601453B/en unknown
- 2006-03-09 IL IL174213A patent/IL174213A0/en unknown
- 2006-03-27 CO CO06030123A patent/CO5680402A2/es not_active Application Discontinuation
- 2006-04-05 IS IS8399A patent/IS8399A/is unknown
- 2006-04-13 MA MA28933A patent/MA28093A1/fr unknown
- 2006-04-24 NO NO20061791A patent/NO20061791L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5680402A2 (es) | 2006-09-29 |
| GB0322629D0 (en) | 2003-10-29 |
| ES2297465T3 (es) | 2008-05-01 |
| PT1667975E (pt) | 2008-02-29 |
| DE602004010410D1 (en) | 2008-01-10 |
| CA2540022A1 (en) | 2005-05-06 |
| WO2005040124A1 (en) | 2005-05-06 |
| IS8399A (is) | 2006-04-05 |
| RU2355681C2 (ru) | 2009-05-20 |
| PL1667975T3 (pl) | 2008-04-30 |
| BRPI0414678A (pt) | 2006-11-28 |
| HK1094190A1 (en) | 2007-03-23 |
| US20070032504A1 (en) | 2007-02-08 |
| MA28093A1 (fr) | 2006-08-01 |
| EP1667975A1 (en) | 2006-06-14 |
| AU2004283805A1 (en) | 2005-05-06 |
| DE602004010410T2 (de) | 2008-10-16 |
| CN1856471A (zh) | 2006-11-01 |
| MXPA06003375A (es) | 2006-06-08 |
| EP1667975B1 (en) | 2007-11-28 |
| IL174213A0 (en) | 2006-08-01 |
| ZA200601453B (en) | 2007-04-25 |
| JP2007506702A (ja) | 2007-03-22 |
| DK1667975T3 (da) | 2008-04-14 |
| RU2006114024A (ru) | 2007-11-10 |
| HRP20080055T3 (en) | 2008-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| DK1648905T3 (da) | Inhibitorer for thienopyridin- og furopyridinkinase | |
| EA200501274A1 (ru) | Пиразолы и способы их получения и применения | |
| TW200504015A (en) | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors | |
| NO20073140L (no) | Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| WO2006050109A3 (en) | Novel kinase inhibitors | |
| NO20006645L (no) | Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme | |
| NO20061791L (no) | Polymorf form av 3-fenylsulfonyl-8-piperazin-1-yl-kinolin | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
| MXPA05009151A (es) | Inhibidores de cinasa heterociclica. | |
| WO2004043379A3 (en) | Chemical compounds | |
| GB0322510D0 (en) | Novel compounds | |
| SE0300850D0 (sv) | Chemical compounds | |
| WO2004032908A3 (en) | Method of inhibiting angiogenesis | |
| HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
| DE60329326D1 (de) | Tace inhibitoren | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| SE0200844D0 (sv) | Chemical compounds | |
| SE0200843D0 (sv) | Chemical compounds | |
| DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| SE0300957D0 (sv) | Chemical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |